INTRODUCTION
Aluminium is known to be toxic both to plants and animals. In humans it has been implicated in Alzheimer's disease (although not necessarily as a cause) by its association with the two major neuropathological features, the neurofibrillary tangle-bearing neurons [1] and senile plaque cores, where it is present as aluminosilicate [2] . Aluminium neurotoxicity, a progressive and fatal encephalopathy, was seen in patients undergoing long-term renal dialysis who had received aluminium-containing dialysate or large oral doses of aluminium hydroxide given to limit phosphate absorption. (Aluminium-containing phosphate-binding compounds are still given to patients to decrease phosphate absorption [3] .) In these patients a range of disorders are found: osteodystrophy, microcytic anaemia and parathyroid suppression.
Quantitative studies [4] have shown that transferrin, the Fe(III)-transport protein, is also the strongest binder of and therefore the ultimate carrier of Al3+ in the blood. Citrate, present at a concentration of 100 mm in plasma, is the most likely small A13+ binder [5] . Al3+-transferrin is bound efficiently by the transferrin receptor and is taken up by the rat K562 cell line almost as efficiently as Fe3+-transferrin [6] . It has been shown [7] that, in renal-dialysis patients, high cortical aluminium concentrations are associated with regions rich in transferrin receptors, e.g. cerebral cortex, supporting the notion that Al3+-transferrin is the means by which aluminium gains entry to cells. Al3+ may thus be internalized by the same mechanism as Fe3+, namely receptor-mediated endocytosis of the transferrinmetal complex followed by release of the metal from the complex in an acidic non-lysosomal compartment [8, 9] .
Once in the cell, some ofthe iron may be utilized for production of haem and non-haem iron-containing enzymes, but in most animal cells the bulk of the iron is found in the storage pool as ferritin or haemosiderin [10] . Studies in vitro suggest that the formation of the iron core in ferritin involves the binding and oxidation of Fe2+ [11] . A similar mechanism could not apply to aluminium since the + 2 oxidation state is not found naturally. However, a significant amount of aluminium could be incorporated into ferritin cores in place of Fe3+ atoms. A lowmolecular-mass iron pool exists in the cytoplasm, which allows transport ofiron between intracellular compartments and enables regulation of intracellular iron concentrations [10] . The to remove any denatured protein. Further traces of thioglycollic acid were removed by precipitating the apoferritin with 400 g of (NH4)2SO4/1.
Aluminium solutions
Three methods were used to prepare aluminium citrate solutions. All stocks were prepared using Milli-Q water (Millipore).
Method A. AlNH4(SO4)2,12H20 (22.7 mg) was dissolved in 90 ml of 5 mM-HCl, and 2 ml of 25 mM-trisodium citrate was added, followed by 2.313 g of solid Mops (sodium salt). The pH was adjusted with HCI to 6.8-7,4, as required, and the volume made up to 100 ml with water. This gave a stock 0.5 mmaluminium citrate solution in 100 mM-Mops buffer (referred to as aluminium solution A).
Method B. A stock solution of 10 mM-AINH4(S04). 12H20/ 10 mM-citric acid/200 mM-Mops (free acid), pH 2.3, was prepared. The solution was diluted 1: 1 with water and then 1: 4 with 100 mM-Mops buffer at the required pH, to give a 1 mmaluminium citrate solution (referred to as aluminium solution B).
Method C. This method is the same as that described in ref. [13] . Equal volumes of stock 10 mM-AlK(S04)2. 12H20 (pH 3.7)
and 10 mM-trisodium citrate (pH 7.9) were mixed and this solution was diluted 1:4 in 100 mM-Mops buffer. NaOH (1 M) was added to give a 1 mM-aluminium citrate solution at the appropriate pH (referred to as aluminium solution C).
The aluminium solutions A, B and C were diluted with 100 mM-Mops buffer at the specified pH at the time of the experiments. 
Colorimetric aluminium assay
The colorimetric assay used was adapted from ref. [16] . It depends on the production of a colour change when aluminium complexes with the dye Catechol Violet. It was designed to measure large volumes (35 ml) of dilute aluminium solutions, e.g. river water. For our purposes the assay was scaled down 50-fold.
The following stock solutions were made: (A) 1 M-HCI; (B) 1 g of 1,10-bathophenanthrolinesulphonate/I (Sigma); (C) 0.094 g of Catechol Violet (Sigma) in 250 ml of water; (D) 150 g of hexamethylenetetra-amine (Sigma) + 8.4 ml ofammonia solution (0.880 specific gravity) in 500 ml of water.
Milli-Q water and acid-washed glassware were used throughout. Samples were prepared in 100 mM-Mops buffer, pH 6.8-7.4, or other suitable buffer. It is important that the final pH of the assay is between 6.0 and 6.2; it was therefore necessary to predetermine the amount of 1 M-HCI needed to give a final pH of 6.1. To a sample containing [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] umol of aluminium in 0.6 ml of 100 mM-Mops or other suitable buffer, 50-100,l of 1 M-HCI (to give a pH of 6.1), 20 1d of reagent B, 80 4t1 of reagent C, 200 ,ul of reagent D were added, followed by Milli-Q water to 1000 ul. A standard curve was prepared from 100 mM-stock AlK(SO4)2,12H20 (ACS-grade reagent from Sigma) in 0.5 g of H2SO4/l, diluted in sample buffer. The absorbance of the solutions was read at 582 nm.
Iron determination
Iron concentrations were measured using modifications (C. M. Morris, personal communication) of methods described previously [17, 18] . The method is based on spectrophotometric determination of an Fe(II) complex with ferrozine.
Reagents were made up in Milli-Q water in acid-washed glassware. Sample (300 ,l), containing 0.5-3 ,ug of Fe, and 300 ,1u of freshly prepared ascorbic acid solution (20 g/l) were mixed and incubated at 42 'C for 1 h; 300 1l of Na P07 in water (40 g/l) and 300 ,1 of trichloroacetic acid solution (250 g/l) were then added and the mixture was placed in a boiling water bath for 10 min. The samples were cooled and centrifuged for 5 min at full speed in an MSE Microcentaur centrifuge. Traces of iron were removed from any precipitate by resuspending it in 100,l volumes of the ascorbic acid, Na2P407 and trichloroacetic acid solutions, with heating for 10 min before re-centrifugation. The supernatants from the two centrifugation steps were combined and the total volume measured. Up to 1 ml of the supernatant was mixed with 0.5 ml of ferrozine reagent, containing 3 g of ferrozine/l (Sigma) and 3 g of neocuproine/l (Sigma) in 5 mm-HCI. Water was added to make the volume up to 2 ml and the absorbance at 562 nm was read. A solution of 100 ,ug of (NH4)2Fe(SO4)2,6H20/ml in 0.5 g of H2SO4/1 was used to prepare a standard curve.
Equilibrium dialysis
Equilibrium dialysis was carried out in a Dianorm R equilibrium dialyser (MSE) and Macro 1 type cells with a working half-cell volume of 1 ml. The two compartments were separated by a regenerated cellulose dialysis membrane with apparent pore-size limit ofeither 3500 Da (Spectrapor 3) or 12000-14000 Da (Spectrapor 2). After equilibration against an equal volume of aluminium-free buffer, the final aluminium concentration was measured in both compartments by graphite furnace atomic absorption spectroscopy. The results are shown in Table 1 and demonstrate that all three aluminium solutions equilibrate fully across the Spectrapor 2 membrane. With the Spectrapor 3 membrane, however, more than 50 % of the aluminium recovered was in compartment 1, indicating that some aluminium did not equilibrate, and was too large to pass through the membrane. The recovery of aluminium citrate prepared by method A was approximately 90 % with both membranes. Recovery was lower for the other two aluminium solutions, suggesting that they bound more readily to the membrane.
Interaction of ferritin with different aluminium citrate solutions studied by equilibrium dialysis A Spectrapor 2 membrane was used for equilibrium-dialysis experiments with ferritin because there was full equilibration of aluminium solutions at both pH 6.8 and pH 7.4. In these experiments different concentrations of aluminium citrate were allowed to equilibrate with ferritin in aluminium-free Mops buffer. The free aluminium concentration (compartment 1) after correction for aluminium binding to the membrane showed a linear relationship with the initial aluminium concentration. The differences between the slopes of the best-fit lines of the protein- (Fig. lc) . Interestingly, the observed pattern of binding to HSF is similar to the binding to the dialysis membrane, as reflected in the recovery rates for the different aluminium solutions shown in Table 1 . The two preparations that had higher binding to the membrane (B and C) also gave -higher binding to HSF. Scatchard plots were not suitable because of the small number of data points and the finding that the amount of aluminium bound to ferritin was proportional to the initial concentration of aluminium. Thus Scatchard plots gave lines which were parallel to the horizontal axis, implying the existence of an infinite number of binding sites. In studying binding of Al3+, and other metals, to animal and plant ferritins and synthetic iron cores using a micropartition method, Sczekan & Joshi [12] observed two types of binding, which were consistent with the existence of high-affinity (Kd = 10-5_10-7 M) metal-binding sites on the core and low-affinity binding sites attributed to aggregation and autoprecipitation on the core surface. This latter type of binding is similar to that reported here. Scezekan & Joshi [12] The solution chemistry of aluminium is complex. At pH < 5, A13+ exists as the octahedral AI(H2O)63+, but as the pH is raised successive deprotonations of water ligands lead to the precipitation of AI(OH)3 which redissolves at alkali pH as a result of the formation of Al(OH)4-. The insolubility of A1(OH)3 limits the total free mononuclear A13+ concentration in aqueous solution to 8 FM at pH 7.4. At this pH most of the aluminium will be in the A1(OH)4-form and the concentration of Al(H20)63+ will not exceed 3 x 10-12 M. Since citrate binds free Al(H2O)63+, the concentration of this species will be even less in the presence of citrate. Once the solubility limit is exceeded, polynuclear species of aluminium will form in a time-dependent manner [19] , even in the presence of citrate [20] . An equimolar solution of A13+ (of more than a few micromolar) and citrate at pH 6.8-7. 7.4 (Fig. lc) and 50 aluminium atoms/molecule with an initial concentration of aluminium of 500 #M (pH 7.4) (results not shown). Our study indicates that this binding is dependent to some extent on the method of preparation of the aluminium citrate solution. In addition, the duration and temperature of incubation may also be important [13] .
The concentration of aluminium in biological tissues is generally very low. In the cerebral cortex, total aluminium concentrations are normally less than 3 ,tg/g of total protein, although this may be increased in renal-dialysis patients [22] . Nevertheless, there will be an excess of small ligands such as citrate and phosphate groups that bind aluminium strongly and may prevent the accumulation of aluminium by ferritin unless the ferritin is turning over rapidly enough to allow its accumulation into growing iron cores. We have recently studied ferritin isolated from the cerebral cortex of normal, Alzheimer'sdisease and renal-dialysis patients and found no significant change in the aluminium concentrations associated with Alzheimer's-disease and renal-dialysis patients [22] . On the basis of our results obtained, in vitro, we conclude that, in the presence of other aluminium chelators which bind the metal efficiently, ferritin will not protect cells from the toxic effects of aluminium by sequestering large amounts of the metal in the iron core. 
